Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OFS Add-on to Tamoxifen in Premenopausal Breast Cancer (DELFINO)
NCT03664895Phase 3Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2018
- Primary completion
- Dec 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide, goserelin in breast cancer, sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
leuprolidegoserelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03664895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03664895.